VolitionRX Ltd. (VNRX)
0.235
0.00 (0.00%)
USD |
NYAM |
Oct 02, 16:00
0.2332
0.00 (0.00%)
After-Hours: 20:00
VolitionRX Shareholders Equity (Quarterly) : -32.16M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -32.16M |
| March 31, 2026 | -31.97M |
| December 31, 2025 | -34.25M |
| September 30, 2025 | -34.64M |
| June 30, 2025 | -31.82M |
| March 31, 2025 | -27.77M |
| December 31, 2024 | -24.91M |
| September 30, 2024 | -21.50M |
| June 30, 2024 | -21.81M |
| March 31, 2024 | -15.61M |
| December 31, 2023 | -7.802M |
| September 30, 2023 | -2.043M |
| June 30, 2023 | 5.844M |
| March 31, 2023 | -2.336M |
| December 31, 2022 | -2.575M |
| September 30, 2022 | 3.298M |
| June 30, 2022 | 4.468M |
| March 31, 2022 | 11.12M |
| December 31, 2021 | 17.94M |
| September 30, 2021 | 21.33M |
| June 30, 2021 | 26.73M |
| March 31, 2021 | 31.22M |
| December 31, 2020 | 16.34M |
| September 30, 2020 | 18.98M |
| June 30, 2020 | 18.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.195M |
| December 31, 2019 | 14.20M |
| September 30, 2019 | 17.80M |
| June 30, 2019 | 16.38M |
| March 31, 2019 | 15.11M |
| December 31, 2018 | 12.14M |
| September 30, 2018 | 15.11M |
| June 30, 2018 | 10.05M |
| March 31, 2018 | 14.01M |
| December 31, 2017 | 9.958M |
| September 30, 2017 | 13.39M |
| June 30, 2017 | 16.58M |
| March 31, 2017 | 18.49M |
| December 31, 2016 | 21.18M |
| September 30, 2016 | 11.81M |
| June 30, 2016 | 14.33M |
| March 31, 2016 | 16.91M |
| December 31, 2015 | 6.044M |
| September 30, 2015 | 7.141M |
| June 30, 2015 | 9.413M |
| March 31, 2015 | 11.08M |
| December 31, 2014 | 0.3682M |
| September 30, 2014 | -4.098M |
| June 30, 2014 | -0.5323M |
| March 31, 2014 | -1.665M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 1.613B |
| Neogen Corp. | 2.093B |
| QuidelOrtho Corp. | 1.775B |
| Aspira Women's Health, Inc. | -7.256M |
| Lucid Diagnostics, Inc. | 10.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.301M |
| Total Liabilities (Quarterly) | 41.38M |
| Debt to Equity Ratio | -0.3547 |
| Current Ratio | 0.3033 |
| Net Debt Paydown Yield | -4.97% |